We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Cognitive Behavioural Therapy (CBT) for Children With Autistic Spectrum Disorders

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2009 by National Healthcare Group, Singapore.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01031511
First Posted: December 14, 2009
Last Update Posted: October 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Nanyang Technological University
Autism Resource Centre, Singapore
Information provided by:
National Healthcare Group, Singapore
  Purpose
Cognitive Behavioural Therapy is an effective intervention program for children with High-Functioning Autistic Spectrum Disorder to remediate anxiety issues.

Condition Intervention Phase
Autism Spectrum Disorder Anxiety Behavioral: Cognitive Behavioural Therapy Other: Social Recreational Early Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Randomised Controlled Trial on the Effect of Cognitive-behavioural Therapy for High-functioning Children With Autistic Spectrum Disorder

Resource links provided by NLM:


Further study details as provided by National Healthcare Group, Singapore:

Primary Outcome Measures:
  • Anxiety level of child [ Time Frame: Pre Treatment, Post-treatment, 3 months follow-up, 6 months follow-up, One year follow-up ]

Secondary Outcome Measures:
  • Parent Stress Level [ Time Frame: Pre Treatment, Post-treatment, 3 months follow-up, 6 months follow-up, One year follow-up ]

Enrollment: 73
Study Start Date: June 2005
Estimated Study Completion Date: February 2011
Estimated Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Treatment Group - CBT Behavioral: Cognitive Behavioural Therapy
16 weekly sessions of 1.5 hrs in small groups of 3-4 children conducted by 2 therapists
No Intervention: Control Group Other: Social Recreational
16 weekly sessions of 1.5 hrs in small groups of 3-4 children, conducted by 2 therapists

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   9 Years to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Assessed to have Autistic Spectrum Disorder, Asperger Syndrome, Pervasive Developmental Disorder, Not Otherwise Specified by the DSM-IV criteria, based on clinical interview, Asperger Syndrome Diagnostic Scale (ASDS) or Autism Diagnostic Observation Schedule (ADOS)
  • Child have a Verbal Comprehension Index of 80 and Perceptual Reasoning Index of 90 and above
  • No change of medication dosage 1 month prior to the commencement of program for the child and through out the duration of the study
  • Written parental consent and assent from children above 12 years old

Exclusion Criteria:

  • Children with Verbal Comprehension Index of 80 and Perceptual Reasoning Index of 90 and below.
  • Children who are undergoing other Cognitive Behavioural treatment program concurrently
  • Those without parental consent will not be able to participate
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01031511


Locations
Singapore
Institute of Mental Health, Singapore
Singapore, Singapore, 168937
Sponsors and Collaborators
National Healthcare Group, Singapore
Nanyang Technological University
Autism Resource Centre, Singapore
Investigators
Principal Investigator: Min Sung Institute of Mental Health, Singapore
  More Information

Responsible Party: Min, Sung / Dr., Institute of Mental Health
ClinicalTrials.gov Identifier: NCT01031511     History of Changes
Other Study ID Numbers: DSRB Ref Code: A/05/091
NMRC/1002/2005 ( Other Grant/Funding Number: National Medical Research Council (Singapore) )
130/2005 ( Other Identifier: Institute of Mental Health (Singapore) Clinical Research Committee )
First Submitted: December 11, 2009
First Posted: December 14, 2009
Last Update Posted: October 12, 2017
Last Verified: February 2009

Keywords provided by National Healthcare Group, Singapore:
High-Functioning Autistic Spectrum Disorder
Anxiety
Cognitive Behavioural Therapy
Social Recreational
Parent Stress

Additional relevant MeSH terms:
Disease
Autism Spectrum Disorder
Autistic Disorder
Child Development Disorders, Pervasive
Pathologic Processes
Neurodevelopmental Disorders
Mental Disorders